Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific KNG1 BDK, BK, KNG ENSG00000113889 Kininogen 1 3 186717276-186743954 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001616, HPA001645, CAB009809 Supported Group enriched 946 kidney: 518.0;liver: 1860.7 rectum: 1.2 UGT1A9 HLUGP4, LUGP4, UGT1AI ENSG00000241119 UDP glucuronosyltransferase 1 family, polypeptide A9 2 233671853-233773300 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 586 kidney: 461.7;liver: 93.2 cerebral cortex: 0.4 ACSM2A A-923A4.1, ACSM2, MGC150530 ENSG00000183747 Acyl-CoA synthetase medium-chain family member 2A 16 20451461-20487667 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA057699 Supported Group enriched 578 kidney: 284.3;liver: 185.7 cerebral cortex: 0.4 HAO2 GIG16, HAOX2 ENSG00000116882 Hydroxyacid oxidase 2 (long chain) 1 119368779-119394130 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 266 kidney: 314.9;liver: 219.3 breast: 1.0 BHMT BHMT1 ENSG00000145692 Betaine--homocysteine S-methyltransferase 5 79111779-79132290 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038285, HPA058310 Supported Supported Cytosol Group enriched 216 kidney: 783.3;liver: 562.6 urinary bladder: 3.1 CYP3A4 CYP3A3 ENSG00000160868 Cytochrome P450, family 3, subfamily A, polypeptide 4 7 99756960-99784265 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033671, HPA072245 Supported Uncertain Cytosol Group enriched 200 duodenum: 849.6;liver: 2446.6;small intestine: 990.4 adrenal gland: 7.1 CYP4A11 CYP4A2, CYP4AII ENSG00000187048 Cytochrome P450, family 4, subfamily A, polypeptide 11 1 46929177-46941484 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 175 kidney: 230.7;liver: 447.9 epididymis: 1.9 APOB ENSG00000084674 Apolipoprotein B 2 21001429-21044073 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016070, HPA049793 Supported Supported Vesicles
Cytosol Group enriched 122 duodenum: 187.7;liver: 619.0;small intestine: 340.0 adipose tissue: 3.1 CREB3L3 CREB-H ENSG00000060566 CAMP responsive element binding protein 3-like 3 19 4153601-4173054 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040671, HPA056228 Supported Group enriched 104 duodenum: 248.3;liver: 61.3;small intestine: 284.6 colon: 1.9 PRODH2 HSPOX1 ENSG00000250799 Proline dehydrogenase (oxidase) 2 19 35799988-35813299 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA051287 Approved Supported Nucleoplasm
Cytosol Group enriched 94 kidney: 132.6;liver: 45.0 testis: 0.9 ACSM2B ACSM2, HXMA, HYST1046 ENSG00000066813 Acyl-CoA synthetase medium-chain family member 2B 16 20536226-20576427 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA057699 Supported Group enriched 85 kidney: 423.8;liver: 261.6 thyroid gland: 4.0 HPD 4-HPPD, 4HPPD, GLOD3, PPD ENSG00000158104 4-hydroxyphenylpyruvate dioxygenase 12 121839527-121863596 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038321, HPA038322 Supported Uncertain Nuclear speckles Group enriched 85 kidney: 526.3;liver: 1290.5 testis: 10.6 CRP PTX1 ENSG00000132693 C-reactive protein, pentraxin-related 1 159712289-159714589 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005036, HPA027367, HPA027396 Supported Group enriched 68 gallbladder: 173.7;liver: 532.4 endometrium: 5.2 C4BPA C4BP ENSG00000123838 Complement component 4 binding protein, alpha 1 207104262-207144972 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000926, HPA001578 Supported Group enriched 64 liver: 994.5;lung: 261.8 cervix: 9.7 SLC22A7 NLT, OAT2 ENSG00000137204 Solute carrier family 22 (organic anion transporter), member 7 6 43295694-43305538 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030220 Approved Group enriched 63 kidney: 50.1;liver: 167.4 testis: 1.7 IGFBP1 AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12 ENSG00000146678 Insulin-like growth factor binding protein 1 7 45888357-45893668 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004445, HPA046972, HPA050640 Supported Approved Golgi apparatus Group enriched 53 endometrium: 120.4;liver: 562.2;placenta: 264.8 fallopian tube: 5.9 DAO DAMOX ENSG00000110887 D-amino-acid oxidase 12 108858932-108901043 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038653, HPA038654 Supported Group enriched 36 kidney: 89.2;liver: 73.8 rectum: 2.2 TM4SF4 il-TMP ENSG00000169903 Transmembrane 4 L six family member 4 3 149473974-149503281 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046430 Supported Approved Plasma membrane
Cytosol Group enriched 34 duodenum: 595.8;gallbladder: 1326.5;liver: 343.7;small intestine: 515.2 stomach: 20.3 UGT1A1 GNT1, UGT1, UGT1A ENSG00000241635 UDP glucuronosyltransferase 1 family, polypeptide A1 2 233760248-233773299 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 33 duodenum: 205.0;liver: 155.7;small intestine: 83.9 kidney: 4.4 ABCG5 STSL ENSG00000138075 ATP-binding cassette, sub-family G (WHITE), member 5 2 43812472-43838865 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA016514 Approved Approved Nucleus Group enriched 32 duodenum: 58.0;liver: 28.3;small intestine: 57.4 gallbladder: 1.4 AGXT2 AGT2 ENSG00000113492 Alanine--glyoxylate aminotransferase 2 5 34998101-35048135 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037382 Approved Group enriched 32 kidney: 196.2;liver: 59.1 small intestine: 4.0 DIO1 TXDI1 ENSG00000211452 Deiodinase, iodothyronine, type I 1 53891239-53911086 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 30 kidney: 146.4;liver: 94.7;thyroid gland: 433.9 fallopian tube: 7.5 SLC28A1 CNT1 ENSG00000156222 Solute carrier family 28 (concentrative nucleoside transporter), member 1 15 84884654-84945796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019551 Supported Group enriched 26 duodenum: 39.0;kidney: 49.1;liver: 35.4;small intestine: 54.7 placenta: 1.6 ABCG8 GBD4 ENSG00000143921 ATP-binding cassette, sub-family G (WHITE), member 8 2 43838964-43878466 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019556 Uncertain Uncertain Vesicles Group enriched 25 duodenum: 51.4;liver: 34.1;small intestine: 56.7 gallbladder: 1.8 OTC ENSG00000036473 Ornithine carbamoyltransferase X 38352545-38421450 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000243, HPA000570 Supported Supported Mitochondria Group enriched 25 duodenum: 117.6;liver: 195.0;small intestine: 98.9 colon: 5.3 ALDH8A1 ALDH12 ENSG00000118514 Aldehyde dehydrogenase 8 family, member A1 6 134917390-134950122 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026292, HPA055414 Supported Approved Centrosome Group enriched 24 kidney: 73.9;liver: 127.6 epididymis: 4.2 CPS1 ENSG00000021826 Carbamoyl-phosphate synthase 1, mitochondrial 2 210477682-210679107 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003781, HPA021400 Supported Approved Nucleoli Group enriched 24 duodenum: 241.2;liver: 697.3;small intestine: 147.2 testis: 15.2 UPB1 BUP1 ENSG00000100024 Ureidopropionase, beta 22 24494107-24528390 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000728 Supported Group enriched 24 kidney: 50.8;liver: 161.3 testis: 4.4 ALDOB ENSG00000136872 Aldolase B, fructose-bisphosphate 9 101420578-101435823 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002198, CAB020827 Supported Group enriched 23 duodenum: 3808.7;kidney: 6531.8;liver: 5081.5;small intestine: 5731.3 gallbladder: 232.6 DPYS DHPase ENSG00000147647 Dihydropyrimidinase 8 104330324-104467053 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024785 Supported Group enriched 22 kidney: 199.0;liver: 245.6 gallbladder: 10.2 FTCD ENSG00000160282 Formimidoyltransferase cyclodeaminase 21 46136262-46155567 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020073, HPA030928, HPA030929, HPA036114 Supported Approved Plasma membrane
Cytosol Group enriched 18 kidney: 100.1;liver: 184.7 testis: 7.7 C19orf80 ANGPTL8, RIFL, TD26 ENSG00000130173 Chromosome 19 open reading frame 80 19 11237450-11241943 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042131 Approved Nucleoplasm
Golgi apparatus Group enriched 17 adipose tissue: 13.8;liver: 63.5 epididymis: 2.2 C4BPB C4BP ENSG00000123843 Complement component 4 binding protein, beta 1 207088842-207099993 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051620 Approved Group enriched 17 liver: 240.3;ovary: 51.9 placenta: 8.7 MTTP ABL, MTP ENSG00000138823 Microsomal triglyceride transfer protein 4 99563761-99623999 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051170, HPA054862 Uncertain Approved Cytosol Group enriched 17 duodenum: 243.0;liver: 133.9;small intestine: 299.0 testis: 13.5 CYP4A22 ENSG00000162365 Cytochrome P450, family 4, subfamily A, polypeptide 22 1 47137435-47149741 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 15 kidney: 33.4;liver: 109.0 epididymis: 4.6 HFE2 haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC ENSG00000168509 Hemochromatosis type 2 (juvenile) 1 146017468-146021918 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 15 heart muscle: 47.4;liver: 123.1;skeletal muscle: 213.2 esophagus: 8.6 GOLGA6B ENSG00000215186 Golgin A6 family, member B 15 72654738-72666394 Predicted intracellular proteins Evidence at protein level Evidence at protein level No evidence HPA044978, HPA050087 Supported Group enriched 14 liver: 1.9;testis: 5.2 cerebral cortex: 0.2 UGT2B7 UGT2B9 ENSG00000171234 UDP glucuronosyltransferase 2 family, polypeptide B7 4 69051363-69112987 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045108 Uncertain Group enriched 14 kidney: 1315.4;liver: 823.8 fallopian tube: 79.1 UPP2 UDRPASE2, UP2, UPASE2 ENSG00000007001 Uridine phosphorylase 2 2 157876702-158136154 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035225, HPA035226 Approved Nucleus
Vesicles
Mitochondria Group enriched 14 kidney: 51.8;liver: 14.4 cerebral cortex: 2.4 GLYATL1 FLJ34646, MGC15397 ENSG00000166840 Glycine-N-acyltransferase-like 1 11 58905398-59043527 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039501 Supported Uncertain Golgi apparatus
Cytosol Group enriched 13 kidney: 144.3;liver: 295.8 prostate: 16.3 NAT2 AAC2 ENSG00000156006 N-acetyltransferase 2 (arylamine N-acetyltransferase) 8 18391245-18401218 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043704 Uncertain Group enriched 13 colon: 14.7;duodenum: 33.6;liver: 62.2;rectum: 14.2;small intestine: 27.7 smooth muscle: 2.3 PROZ PZ ENSG00000126231 Protein Z, vitamin K-dependent plasma glycoprotein 13 113158654-113172383 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052006 Approved Group enriched 13 kidney: 14.5;liver: 27.4 testis: 1.6 CNDP1 CN1, CPGL2, HsT2308, MGC10825 ENSG00000150656 Carnosine dipeptidase 1 (metallopeptidase M20 family) 18 74534440-74587212 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008933 Supported Group enriched 12 cerebral cortex: 102.0;liver: 23.0 duodenum: 5.2 GPR88 ENSG00000181656 G protein-coupled receptor 88 1 100538137-100542018 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007488 Uncertain Approved Group enriched 12 breast: 9.7;cerebral cortex: 3.1;liver: 5.1;ovary: 3.4;parathyroid gland: 7.9;spleen: 14.7 adipose tissue: 0.6 HABP2 FSAP, HABP, HGFAL, PHBP ENSG00000148702 Hyaluronan binding protein 2 10 113550837-113589602 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019518 Approved Group enriched 12 gallbladder: 56.0;liver: 225.6 stomach: 11.5 MOGAT2 DGAT2L5, FLJ22644, MGAT2 ENSG00000166391 Monoacylglycerol O-acyltransferase 2 11 75717819-75732958 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028834 Uncertain Group enriched 12 colon: 12.7;duodenum: 38.2;liver: 12.1;rectum: 12.7;small intestine: 44.5 appendix: 2.0 NR1I2 BXR, ONR1, PAR2, PXR, SXR ENSG00000144852 Nuclear receptor subfamily 1, group I, member 2 3 119780484-119818485 FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA029309, HPA055121, HPA073926 Validated Nucleoplasm Group enriched 12 colon: 9.3;duodenum: 23.2;gallbladder: 6.0;liver: 19.7;rectum: 9.4;small intestine: 26.3 stomach: 1.3 SLC39A5 ENSG00000139540 Solute carrier family 39 (zinc transporter), member 5 12 56230049-56237846 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018423 Approved Nucleoplasm
Vesicles
Cytosol Group enriched 12 colon: 74.5;duodenum: 247.0;kidney: 114.6;liver: 85.7;pancreas: 53.1;rectum: 49.7;small intestine: 245.4 gallbladder: 10.0 CLDN14 DFNB29 ENSG00000159261 Claudin 14 21 36460621-36576569 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 11 kidney: 3.6;liver: 9.6 gallbladder: 0.6 DMGDH ENSG00000132837 Dimethylglycine dehydrogenase 5 78997606-79236038 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036441, HPA036442, HPA077849 Supported Uncertain Mitochondria Group enriched 11 kidney: 177.8;liver: 146.1 epididymis: 14.7 F5 ENSG00000198734 Coagulation factor V (proaccelerin, labile factor) 1 169514166-169586588 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002036 Uncertain Approved Golgi apparatus Group enriched 11 gallbladder: 28.5;liver: 93.7;placenta: 67.7 fallopian tube: 5.8 KHK ENSG00000138030 Ketohexokinase (fructokinase) 2 27086747-27100772 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007040 Supported Approved Cytosol Group enriched 11 duodenum: 116.2;kidney: 111.0;liver: 97.3;small intestine: 135.8 cerebral cortex: 10.1 SRD5A2 ENSG00000277893 Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) 2 31522480-31581067 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 11 epididymis: 27.4;fallopian tube: 31.2;liver: 30.6;prostate: 25.3;seminal vesicle: 24.2 testis: 2.4 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Approved Group enriched 10 duodenum: 44.7;gallbladder: 42.8;kidney: 20.8;liver: 67.6;small intestine: 50.5 breast: 4.3 ACMSD ENSG00000153086 Aminocarboxymuconate semialdehyde decarboxylase 2 134838547-134902034 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010533, HPA011179 Supported Uncertain Cytosol Group enriched 10 kidney: 136.5;liver: 80.0 gallbladder: 10.9 CYP2C18 CPCI, CYP2C, CYP2C17, P450IIC17 ENSG00000108242 Cytochrome P450, family 2, subfamily C, polypeptide 18 10 94683621-94736190 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 10 duodenum: 105.9;esophagus: 24.7;gallbladder: 24.5;liver: 97.7;small intestine: 90.0;stomach: 62.7 tonsil: 6.4 GLYAT ACGNAT, GAT ENSG00000149124 Glycine-N-acyltransferase 11 58640426-58731974 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040251, HPA044094 Supported Group enriched 10 kidney: 579.6;liver: 353.8 adipose tissue: 47.4 PLA2G12B PLA2G13 ENSG00000138308 Phospholipase A2, group XIIB 10 72935170-72954778 Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA057745, HPA059562 Approved Approved Vesicles Group enriched 10 duodenum: 36.2;kidney: 18.9;liver: 49.8;small intestine: 46.9 lung: 3.9 CDHR5 FLJ20219, MU-PCDH, MUCDHL, MUPCDH ENSG00000099834 Cadherin-related family member 5 11 616565-626078 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009081, HPA009173, CAB025004 Supported Group enriched 9 colon: 42.5;duodenum: 85.2;kidney: 23.4;liver: 20.6;rectum: 55.1;small intestine: 65.8 gallbladder: 5.3 GNMT ENSG00000124713 Glycine N-methyltransferase 6 42960758-42963880 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027501 Supported Approved Cytosol Group enriched 9 liver: 154.6;pancreas: 55.8;prostate: 34.2 breast: 9.3 HRSP12 P14.5, PSP, UK114 ENSG00000132541 Heat-responsive protein 12 8 98102344-98117241 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA022856, HPA023489 Supported Group enriched 9 kidney: 451.5;liver: 696.6 cerebral cortex: 62.5 HSD11B1 HSD11, HSD11B, SDR26C1 ENSG00000117594 Hydroxysteroid (11-beta) dehydrogenase 1 1 209686178-209734950 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047729 Supported Group enriched 9 liver: 491.1;placenta: 104.6 ovary: 31.5 ASCL1 ASH1, bHLHa46, HASH1 ENSG00000139352 Achaete-scute family bHLH transcription factor 1 12 102957686-102960516 Predicted secreted proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA029217 Supported Group enriched 8 cerebral cortex: 16.3;liver: 6.5 adrenal gland: 1.4 CLRN3 MGC32871, TMEM12, USH3AL1 ENSG00000180745 Clarin 3 10 127877841-127892947 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014482 Approved Group enriched 8 colon: 71.2;duodenum: 75.4;gallbladder: 23.7;kidney: 43.9;liver: 40.2;rectum: 77.5;small intestine: 99.5 appendix: 7.5 COLEC10 CL-L1 ENSG00000184374 Collectin sub-family member 10 (C-type lectin) 8 118995452-119106582 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 8 liver: 51.1;placenta: 25.7 thyroid gland: 4.9 CYP1A1 CP11, CYP1, P1-450, P450-C, P450DX ENSG00000140465 Cytochrome P450, family 1, subfamily A, polypeptide 1 15 74719542-74725610 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB018654 Uncertain Group enriched 8 liver: 33.8;small intestine: 21.0;urinary bladder: 84.1 breast: 5.7 ETNPPL AGXT2L1 ENSG00000164089 Ethanolamine-phosphate phospho-lyase 4 108742040-108763054 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044546, HPA072938 Approved Approved Nucleus Group enriched 8 cerebral cortex: 141.6;liver: 98.5 stomach: 14.7 HAL HIS ENSG00000084110 Histidine ammonia-lyase 12 95972662-95996365 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038547, HPA038548 Supported Uncertain Cytosol Group enriched 8 liver: 51.0;skin: 72.6 bone marrow: 7.4 PFKFB1 PFRX ENSG00000158571 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 X 54932961-54998534 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 8 adipose tissue: 30.0;liver: 18.9;skeletal muscle: 39.3 breast: 3.8 REEP6 C19orf32, DP1L1, FLJ25383 ENSG00000115255 Receptor accessory protein 6 19 1490747-1497927 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003895, HPA048015 Approved Supported Endoplasmic reticulum Group enriched 8 adrenal gland: 48.4;duodenum: 170.8;liver: 76.3;small intestine: 170.5;testis: 181.6 prostate: 17.0 SEC14L4 dJ130H16.5, TAP3 ENSG00000133488 SEC14-like lipid binding 4 22 30488913-30505711 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069748 Approved Centrosome Group enriched 8 bone marrow: 5.0;liver: 10.3;lung: 6.9;parathyroid gland: 10.3;testis: 7.1 adrenal gland: 0.9 ASPDH ENSG00000204653 Aspartate dehydrogenase domain containing 19 50511600-50514690 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042631, HPA042654 Approved Group enriched 7 cerebral cortex: 17.9;duodenum: 7.1;kidney: 27.9;liver: 34.6 adrenal gland: 3.3 ATF5 ENSG00000169136 Activating transcription factor 5 19 49928702-49933935 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA030187 Uncertain Supported Nucleoplasm
Cytosol Group enriched 7 liver: 387.7;thyroid gland: 190.1 appendix: 43.6 C6 ENSG00000039537 Complement component 6 5 41142234-41261438 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043823, CAB069427 Supported Group enriched 7 fallopian tube: 72.6;liver: 357.7 heart muscle: 30.6 CES1 CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1 ENSG00000198848 Carboxylesterase 1 16 55802851-55833337 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012023, HPA046717 Supported Validated Endoplasmic reticulum Group enriched 7 gallbladder: 400.5;liver: 1099.6;lung: 229.6 adipose tissue: 79.7 CLEC4M CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN ENSG00000104938 C-type lectin domain family 4, member M 19 7763149-7769605 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033689, CAB033691, HPA042661 Supported Group enriched 7 liver: 34.7;lymph node: 20.6;placenta: 12.4 testis: 3.3 EHHADH ECHD ENSG00000113790 Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase 3 185190624-185281990 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036401, HPA042021 Supported Group enriched 7 kidney: 147.7;liver: 173.2 duodenum: 22.0 FABP1 L-FABP ENSG00000163586 Fatty acid binding protein 1, liver 2 88122982-88128116 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002305, HPA028275 Supported Approved Nucleoplasm
Cytosol Group enriched 7 colon: 4641.2;duodenum: 4243.6;liver: 5656.0;rectum: 3161.5;small intestine: 4603.3 kidney: 599.7 GCGR GGR ENSG00000215644 Glucagon receptor 17 81804132-81814013 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071228 Approved Golgi apparatus Group enriched 7 adrenal gland: 6.6;kidney: 8.5;liver: 20.9;parathyroid gland: 9.4 skin: 1.6 HNF4A HNF4, MODY, MODY1, NR2A1, TCF14 ENSG00000101076 Hepatocyte nuclear factor 4, alpha 20 44355700-44434596 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004712, CAB019417 Supported Supported Nucleoplasm Group enriched 7 colon: 58.9;duodenum: 105.9;kidney: 44.3;liver: 50.9;rectum: 48.5;small intestine: 92.8;stomach: 22.1 gallbladder: 9.2 IDO2 INDOL1 ENSG00000188676 Indoleamine 2,3-dioxygenase 2 8 39934614-40016391 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 liver: 2.6;placenta: 5.8 testis: 0.5 IGSF23 ENSG00000216588 Immunoglobulin superfamily, member 23 19 44613630-44636781 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051811, HPA054591 Uncertain Approved Nucleus
Cell Junctions Group enriched 7 duodenum: 15.6;liver: 13.1;small intestine: 17.8 testis: 2.3 NEU4 ENSG00000204099 Sialidase 4 2 241808825-241817413 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA037394, HPA037395 Uncertain Group enriched 7 bone marrow: 2.4;cerebral cortex: 6.4;colon: 8.5;duodenum: 5.7;liver: 4.1;rectum: 3.9;small intestine: 5.4 gallbladder: 0.8 PIPOX LPIPOX ENSG00000179761 Pipecolic acid oxidase 17 28950513-29057220 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 kidney: 136.7;liver: 235.2 epididymis: 26.2 SULT1E1 EST, STE ENSG00000109193 Sulfotransferase family 1E, estrogen-preferring, member 1 4 69810780-69860152 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028213, HPA028728, CAB047344 Supported Group enriched 7 duodenum: 28.4;liver: 18.7;skin: 7.6;small intestine: 30.3 adrenal gland: 3.1 TBX15 TBX14 ENSG00000092607 T-box 15 1 118883046-118989556 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA052245, HPA053713 Uncertain Approved Nucleoplasm
Centrosome Group enriched 7 adipose tissue: 17.0;breast: 8.8;liver: 24.1;skeletal muscle: 42.2 lymph node: 3.2 UGT2A1 ENSG00000173610 UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus 4 69588417-69653249 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA017261, HPA045108 Uncertain Group enriched 7 kidney: 8.1;liver: 5.5 skin: 0.9 ACY1 ENSG00000243989 Aminoacylase 1 3 51983340-51989197 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003695, HPA036174, HPA036175 Supported Group enriched 6 duodenum: 182.6;kidney: 462.6;liver: 146.9;small intestine: 158.4 thyroid gland: 40.0 ADGRG7 FLJ14454, GPR128 ENSG00000144820 Adhesion G protein-coupled receptor G7 3 100609589-100695479 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 duodenum: 44.0;liver: 12.4;small intestine: 43.8 colon: 5.4 ADH1B ADH2 ENSG00000196616 Alcohol dehydrogenase 1B (class I), beta polypeptide 4 99304964-99321401 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047814, HPA060902 Supported Approved Plasma membrane
Cytosol Group enriched 6 adipose tissue: 1534.1;liver: 2889.4 lung: 371.7 BHMT2 ENSG00000132840 Betaine--homocysteine S-methyltransferase 2 5 79069717-79089466 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044573 Supported Group enriched 6 kidney: 360.3;liver: 238.4 epididymis: 46.4 C8G ENSG00000176919 Complement component 8, gamma polypeptide 9 136945246-136946974 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046269 Approved Uncertain Endoplasmic reticulum Group enriched 6 duodenum: 51.3;liver: 106.1;small intestine: 35.3 gallbladder: 9.9 CETP BPIFF ENSG00000087237 Cholesteryl ester transfer protein, plasma 16 56961850-56983845 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 adipose tissue: 36.8;liver: 21.6;lymph node: 47.1;placenta: 50.0;spleen: 79.2 thyroid gland: 8.4 CLEC4G LSECtin, UNQ431 ENSG00000182566 C-type lectin domain family 4, member G 19 7728957-7733906 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003789, HPA014044 Supported Group enriched 6 adipose tissue: 18.5;liver: 27.6;lymph node: 17.0 urinary bladder: 3.5 CYP4F2 ENSG00000186115 Cytochrome P450, family 4, subfamily F, polypeptide 2 19 15878023-15898120 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014048, HPA017265, HPA058960 Supported Group enriched 6 duodenum: 80.4;epididymis: 27.5;kidney: 39.1;liver: 84.6;small intestine: 86.1 prostate: 10.6 DCXR DCR, KIDCR, SDR20C1 ENSG00000169738 Dicarbonyl/L-xylulose reductase 17 82035136-82037732 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023371, HPA023863 Supported Uncertain Nucleoli
Microtubules Group enriched 6 epididymis: 292.3;kidney: 216.4;liver: 638.6;prostate: 134.3 adipose tissue: 56.5 DNMT3L MGC1090 ENSG00000142182 DNA (cytosine-5-)-methyltransferase 3-like 21 44246339-44262216 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA055234, HPA066780 Uncertain Approved Nuclear speckles Group enriched 6 kidney: 7.4;liver: 10.8;lymph node: 2.3 spleen: 1.1 FCN3 FCNH, HAKA1 ENSG00000142748 Ficolin (collagen/fibrinogen domain containing) 3 1 27369112-27374824 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025945 Approved Group enriched 6 liver: 143.5;lung: 267.2 placenta: 32.8 GATM AGAT ENSG00000171766 Glycine amidinotransferase (L-arginine:glycine amidinotransferase) 15 45361124-45402327 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026077 Supported Supported Mitochondria Group enriched 6 kidney: 1889.7;liver: 1289.2;pancreas: 573.5 ovary: 194.5 IGFALS ALS ENSG00000099769 Insulin-like growth factor binding protein, acid labile subunit 16 1790413-1794971 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040692, HPA040948 Approved Supported Nucleoplasm Group enriched 6 liver: 25.1;stomach: 6.6 gallbladder: 2.5 ONECUT1 HNF-6, HNF6, HNF6A ENSG00000169856 One cut homeobox 1 15 52756989-52791078 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA003457 Approved Group enriched 6 gallbladder: 8.5;liver: 5.9;pancreas: 2.3;testis: 1.8 bone marrow: 0.7 PCK2 PEPCK, PEPCK2 ENSG00000100889 Phosphoenolpyruvate carboxykinase 2 (mitochondrial) 14 24094053-24110598 Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018734, HPA051162, HPA053502 Supported Validated Mitochondria Group enriched 6 duodenum: 377.7;kidney: 191.6;liver: 258.5;small intestine: 282.4 colon: 47.9 PRAP1 UPA ENSG00000165828 Proline-rich acidic protein 1 10 133309410-133352683 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035360, HPA038713, HPA052451 Supported Approved Nucleoplasm
Vesicles
Plasma membrane Group enriched 6 duodenum: 981.7;liver: 306.9;small intestine: 1145.9 kidney: 136.1 SERPINA3 ENSG00000273259 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 14 94592058-94624646 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA000893, HPA002560 Supported Group enriched 6 cervix, uterine: 377.8;liver: 1692.1 gallbladder: 159.7 SLC17A4 KIAA2138 ENSG00000146039 Solute carrier family 17, member 4 6 25754699-25781191 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055564 Approved Group enriched 6 colon: 20.8;duodenum: 29.4;gallbladder: 25.5;liver: 22.4;rectum: 29.4;small intestine: 35.7 pancreas: 4.2 TMPRSS6 FLJ30744 ENSG00000187045 Transmembrane protease, serine 6 22 37065436-37109563 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 liver: 40.7;testis: 8.7 stomach: 4.1 UGT1A6 GNT1, HLUGP, UGT1F ENSG00000167165 UDP glucuronosyltransferase 1 family, polypeptide A6 2 233691607-233773300 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009819, HPA054065 Supported Group enriched 6 kidney: 74.7;liver: 71.9;urinary bladder: 112.0 esophagus: 15.2 UGT2B15 UGT2B8 ENSG00000196620 UDP glucuronosyltransferase 2 family, polypeptide B15 4 68537413-68670628 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045108 Approved Group enriched 6 colon: 23.8;duodenum: 30.6;gallbladder: 114.5;liver: 108.6;small intestine: 33.9 stomach: 10.2 AADAC CES5A1, DAC ENSG00000114771 Arylacetamide deacetylase 3 151814037-151828488 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002911 Approved Group enriched 5 adrenal gland: 151.1;duodenum: 187.8;liver: 385.8;small intestine: 220.5 stomach: 43.9 AKR1C2 BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD ENSG00000151632 Aldo-keto reductase family 1, member C2 10 4922564-5135226 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB047304, HPA068265 Approved Approved Nucleus
Nucleoli fibrillar center
Endoplasmic reticulum
Cytosol Group enriched 5 adipose tissue: 352.3;breast: 122.0;esophagus: 118.4;gallbladder: 189.9;liver: 186.5;stomach: 138.5;urinary bladder: 186.3 duodenum: 33.7 AOX1 AO, AOH1 ENSG00000138356 Aldehyde oxidase 1 2 200585868-200677064 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040199, HPA040215 Approved Supported Nuclear bodies
Cytosol Group enriched 5 adrenal gland: 370.6;kidney: 96.7;liver: 432.0 ovary: 56.6 FOXA3 HNF3G ENSG00000170608 Forkhead box A3 19 45863989-45873797 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level CAB015154, HPA054034 Uncertain Approved Nucleoplasm Group enriched 5 colon: 17.0;duodenum: 10.6;liver: 32.5;pancreas: 9.8;rectum: 18.2;small intestine: 14.2;stomach: 34.1 gallbladder: 3.6 GHR GHBP ENSG00000112964 Growth hormone receptor 5 42423777-42721878 Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045339, HPA057705 Supported Supported Plasma membrane
Cytosol
Cytoplasmic bodies Group enriched 5 adipose tissue: 91.1;liver: 110.5 prostate: 18.4 GSTA2 GST2 ENSG00000244067 Glutathione S-transferase alpha 2 6 52750089-52763569 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004342, HPA048934, HPA053817 Supported Supported Cytosol Group enriched 5 kidney: 646.8;liver: 983.1 gallbladder: 156.1 LBP BPIFD2 ENSG00000129988 Lipopolysaccharide binding protein 20 38346356-38377023 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001508, CAB025905 Approved Group enriched 5 adipose tissue: 68.5;liver: 264.3 appendix: 31.9 RP11-407N17.3 ENSG00000258941 14 39233902-39350423 Predicted membrane proteins Evidence at protein level Evidence at protein level HPA000387, HPA000922, HPA054066, HPA055459 Uncertain Approved Endoplasmic reticulum Group enriched 5 duodenum: 16.1;kidney: 10.3;liver: 13.3;parathyroid gland: 21.0;small intestine: 19.1 gallbladder: 3.0 SERPINA3 AACT, ACT, alpha-1-antichymotrypsin ENSG00000196136 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 14 94612384-94624055 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000893, HPA002560, CAB016647 Supported Group enriched 5 cervix, uterine: 133.1;liver: 607.5 gallbladder: 69.4 SLC27A2 ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS ENSG00000140284 Solute carrier family 27 (fatty acid transporter), member 2 15 50182196-50236395 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026089 Supported Group enriched 5 epididymis: 79.2;kidney: 160.9;liver: 145.2 placenta: 24.5 SLC6A1 GABATHG, GABATR, GAT1 ENSG00000157103 Solute carrier family 6 (neurotransmitter transporter), member 1 3 10992724-11039247 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013341, CAB022293 Supported Uncertain Mitochondria Group enriched 5 cerebral cortex: 119.7;liver: 50.3 parathyroid gland: 15.7 SMLR1 ENSG00000256162 Small leucine-rich protein 1 6 130827406-130837135 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA066060 Uncertain Group enriched 5 duodenum: 12.5;liver: 28.9;small intestine: 11.6 kidney: 3.2 VNN1 Tiff66 ENSG00000112299 Vanin 1 6 132681590-132714049 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064145 Approved Group enriched 5 duodenum: 176.1;gallbladder: 175.5;liver: 142.6;small intestine: 108.8 kidney: 27.4